Search results
Management of Heart Failure in Patients Nearing the End of Life - There is So Much More To Do
Author(s):
Lisa LeMond
,
Sarah J Goodlin
Added:
3 years ago
Article
Author(s):
Ali Vazir
,
Kostantinos Bronis
,
Simon G Pearse
Added:
3 years ago
Central sleep apnoea (CSA) is characterised by cycles of apnoea, hypopnoea and hyperpnoea during sleep due to abnormalities in the regulation of breathing within the respiratory centre in the brainstem. CSA, defined as an apnoea–hypopnoea index (AHI) of ≥15 events/h, is common in patients with heart failure (HF), with a prevalence of 20–45 %.1, 2 Its presence is reported to be a marker of…
View more
Author(s):
Tonje Thorvaldsen
,
Lars H Lund
Added:
3 years ago
Heart failure (HF) is associated with poor quality of life, high risk of death and is the leading cause of hospitalisation.1 With an ageing population and improved care for cardiovascular diseases, the prevalence of HF is increasing. Despite advances in HF therapies, 1–10% of the population with HF progress to an advanced stage of the disease.2,3 In the US, an estimated 250,000–300,000 patients…
View more
Author(s):
Oren Caspi
,
Doron Aronson
Added:
3 years ago
Heart failure is a growing pandemic worldwide, and it is associated with a high burden of morbidity and mortality. Acute heart failure (AHF) is one of the most prevalent causes of adult patients’ hospitalisation. While the treatment of most cardiovascular diseases has significantly improved since the beginning of this century, the outcomes of AHF have not progressed significantly, and AHF still…
View more
Author(s):
Sarah H Cross
,
Arif H Kamal
,
Donald H Taylor Jr
,
et al
Added:
3 years ago
Heart failure (HF) is estimated to affect 26 million people worldwide and is responsible for an annual global economic burden of US$108 billion.1,2 An ageing population and a reduction in mortality from other conditions such as acute MI are expected to result in an increased HF prevalence throughout much of the world.1,3–6 The prevalence of HF has particularly increased among those aged 85 years…
View more
Author(s):
Ovidiu Chioncel
,
Sean P Collins
,
Andrew P Ambrosy
,
et al
Added:
3 years ago
Acute heart failure (AHF) is a heterogeneous clinical syndrome including diverse phenotypes sharing similar presenting signs and symptoms.1 The diversity of aetiologies and precipitants of HF and their specific pathophysiologic mechanisms, may result in distinct clinical profiles requiring specific treatment approaches.
Pulmonary oedema (PO) is a common manifestation of AHF associated with a…
View more